Cover Book

Region : Global | Format: PDF | Report ID: GMS16786

GLP-1 Drug Market Size, Share, Growth, and Industry Analysis, By Type (Short-acting GLP-1 Drug, Long-acting GLP-1 Drug), By Application (Obesity, Type 2 Diabetes (T2DM), Cardiovascular and Cerebrovascular Diseases (CVD), Non-alcoholic Steatohepatitis (NASH), Alzheimer's Disease (AD)), Regional Insights and Forecast to 2035

GLP-1 Drug Market size was valued at USD 47601.19 million in 2026 and is expected to reach USD 641817.37 million by 2035, growing at a CAGR of 26.7% from 2026 to 2035.... Read More

Final Report includes Impact of Covid-19 and Russia Ukrain Conflict
Clients Who Trust and Rely On Us For Their Market Research Needs
google
sony
samsung
ups
ey
yamaha
mckinsey&company
deliote
daikin
duracel
nvidia
fizer
hoerbiger
abbott
stallergenesgreer
novonordisk
hitachi
american express
bosch

Download Free Sample

man icon
Mail icon
Mail icon
Mail icon
Captcha refresh